Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 gemcitabine + oxaliplatin in relapsed or refractory pediatric solid tumors
2006-001065-41Phase 2Completed
- Sponsor
- Gustave Roussy
- Start
- Dec 2006
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, oxaliplatin in Non-hematologic malignancy, central nervous system tumor, medulloblastoma, neuroblastoma, osteosarcoma (OS), sponsored by Gustave Roussy. Started Dec 2006; status: completed.
02
Drugs
gemcitabineoxaliplatin
03
Conditions
Non-hematologic malignancycentral nervous system tumormedulloblastomaneuroblastomaosteosarcoma (OS)
Beyond the preview
Go deeper on 2006-001065-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001065-41.